A detailed history of Geode Capital Management, LLC transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 626,912 shares of KZR stock, worth $4.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
626,912
Previous 545,234 14.98%
Holding current value
$4.09 Million
Previous $327,000 47.4%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.53 - $0.77 $43,289 - $62,892
81,678 Added 14.98%
626,912 $482,000
Q2 2024

Aug 09, 2024

SELL
$0.6 - $0.92 $497,073 - $762,178
-828,455 Reduced 60.31%
545,234 $327,000
Q1 2024

May 13, 2024

BUY
$0.8 - $1.05 $15,232 - $19,993
19,041 Added 1.41%
1,373,689 $1.24 Million
Q4 2023

Feb 13, 2024

BUY
$0.72 - $1.15 $44,662 - $71,335
62,031 Added 4.8%
1,354,648 $1.29 Million
Q3 2023

Nov 13, 2023

BUY
$1.08 - $2.54 $60,327 - $141,881
55,859 Added 4.52%
1,292,617 $1.54 Million
Q2 2023

Aug 11, 2023

BUY
$2.31 - $3.06 $466,155 - $617,504
201,799 Added 19.5%
1,236,758 $3.03 Million
Q1 2023

May 15, 2023

BUY
$3.13 - $7.31 $181,768 - $424,513
58,073 Added 5.94%
1,034,959 $3.24 Million
Q4 2022

Feb 13, 2023

BUY
$6.39 - $8.8 $229,956 - $316,685
35,987 Added 3.82%
976,886 $6.88 Million
Q3 2022

Nov 14, 2022

BUY
$7.99 - $10.75 $1.32 Million - $1.77 Million
164,785 Added 21.23%
940,899 $8.1 Million
Q2 2022

Aug 12, 2022

BUY
$4.58 - $17.13 $466,637 - $1.75 Million
101,886 Added 15.11%
776,114 $6.42 Million
Q1 2022

May 13, 2022

BUY
$12.3 - $18.33 $690,804 - $1.03 Million
56,163 Added 9.09%
674,228 $11.2 Million
Q4 2021

Feb 11, 2022

BUY
$7.44 - $16.72 $99,599 - $223,830
13,387 Added 2.21%
618,065 $10.3 Million
Q3 2021

Nov 12, 2021

BUY
$4.85 - $9.73 $151,412 - $303,760
31,219 Added 5.44%
604,678 $5.22 Million
Q2 2021

Aug 13, 2021

BUY
$4.93 - $6.46 $301,346 - $394,867
61,125 Added 11.93%
573,459 $3.11 Million
Q1 2021

May 12, 2021

BUY
$5.24 - $6.99 $219,178 - $292,377
41,828 Added 8.89%
512,334 $3.05 Million
Q4 2020

Feb 12, 2021

BUY
$4.77 - $6.58 $197,721 - $272,747
41,451 Added 9.66%
470,506 $2.46 Million
Q3 2020

Nov 13, 2020

BUY
$4.36 - $5.5 $43,844 - $55,308
10,056 Added 2.4%
429,055 $2.08 Million
Q2 2020

Aug 13, 2020

SELL
$3.6 - $7.75 $12,686 - $27,311
-3,524 Reduced 0.83%
418,999 $2.17 Million
Q1 2020

May 14, 2020

BUY
$2.77 - $5.75 $811,817 - $1.69 Million
293,075 Added 226.4%
422,523 $1.84 Million
Q4 2019

Feb 13, 2020

BUY
$2.5 - $4.26 $9,650 - $16,443
3,860 Added 3.07%
129,448 $519,000
Q3 2019

Nov 12, 2019

BUY
$3.0 - $7.58 $13,998 - $35,368
4,666 Added 3.86%
125,588 $411,000
Q2 2019

Aug 14, 2019

BUY
$7.09 - $21.9 $192,465 - $594,497
27,146 Added 28.95%
120,922 $932,000
Q1 2019

May 14, 2019

BUY
$16.83 - $23.75 $601,335 - $848,587
35,730 Added 61.55%
93,776 $1.66 Million
Q4 2018

Feb 13, 2019

BUY
$20.21 - $32.9 $655,632 - $1.07 Million
32,441 Added 126.7%
58,046 $1.37 Million
Q3 2018

Nov 13, 2018

BUY
$15.5 - $21.41 $396,877 - $548,203
25,605 New
25,605 $548,000

Others Institutions Holding KZR

About Kezar Life Sciences, Inc.


  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $446M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.